6 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24900443	158	Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models.	TBA
19610618	41	Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.	University of South Florida
18788731	42	Design, synthesis, and structure-activity relationships of novel insulin receptor tyrosine kinase activators.	Telik
15771419	134	Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety.	Johnson & Johnson Pharmaceutical Research & Development
9748366	6	Naamidine A is an antagonist of the epidermal growth factor receptor and an in vivo active antitumor agent.	University of Utah
28988628	2	Challenges in the design of insulin and relaxin/insulin-like peptide mimetics.	University of Melbourne